| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691985A1 Phosphonomethyldipeptides |
| 01/17/1996 | EP0691973A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS |
| 01/17/1996 | EP0691972A1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
| 01/17/1996 | EP0691852A1 Prodrugs with enhanced penetration into cells |
| 01/17/1996 | EP0691849A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
| 01/17/1996 | EP0691847A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 01/17/1996 | EP0691844A1 Method for treating amyloidosis |
| 01/17/1996 | EP0691814A1 Method and composition for treatment of osteoporosis |
| 01/17/1996 | EP0635014B1 Indole derivatives as 5-ht1-like agonists |
| 01/17/1996 | EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | CN1115181A Process for the preparation of 9-amino camptothecin |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 01/17/1996 | CN1114876A Use of a spin trap in a cosmetic or dermatological composition |
| 01/17/1996 | CN1030702C 芪衍生物 Stilbene derivatives |
| 01/17/1996 | CN1030701C Indole derivatives and process for production thereof |
| 01/16/1996 | US5484951 Treatment of aids, herpes, cytomegalo virus, antitumor agents |
| 01/16/1996 | US5484944 Anxiety, sleep, memory |
| 01/16/1996 | US5484926 HIV protease inhibitors |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484805 Heterocyclene derivatives |
| 01/16/1996 | US5484804 Perhydroisoindole derivatives as antagonists of substance P |
| 01/16/1996 | US5484803 Transcutaneous in vivo activation of photosensitive agents in blood |
| 01/16/1996 | US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis |
| 01/16/1996 | US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation |
| 01/16/1996 | US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484782 (E)-20(22)-dehydrovitamin D compounds |
| 01/16/1996 | US5484781 (E)-20(22)-dehydrovitamin D compounds |
| 01/16/1996 | US5484780 Angiotensin II antagonists |
| 01/16/1996 | US5484774 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias |
| 01/16/1996 | US5484770 Peptide compounds which inhibit the proliferation of epidermal or epithelial stem cells |
| 01/16/1996 | US5484612 Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/11/1996 | WO1996000736A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |
| 01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000720A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 01/11/1996 | WO1996000716A1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 01/11/1996 | WO1996000584A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 01/11/1996 | WO1996000582A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/11/1996 | WO1996000574A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000572A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
| 01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
| 01/11/1996 | CA2192682A1 New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations |
| 01/11/1996 | CA2191605A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | CA2191604A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 01/11/1996 | CA2190977A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
| 01/10/1996 | EP0691345A2 HIV protease inhibitor combinations |
| 01/10/1996 | EP0691342A1 Benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0691129A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0690918A1 Protein tyrosine phosphatase ptp-s31 |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690850A1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists |
| 01/10/1996 | EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 01/10/1996 | EP0690847A1 Heterocyclic compounds as platelet aggregation inhibitors |
| 01/10/1996 | EP0690843A1 Indoletetralins having dopaminergic activity |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
| 01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0556329B1 Substituted piperazines as central nervous system agents |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/10/1996 | EP0482081B1 Antiviral composition |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/10/1996 | CN1114651A 3-indolylpiperidine |
| 01/10/1996 | CN1114650A MDR reversal agents |
| 01/10/1996 | CN1114564A New medicine for curing vascular system disease |
| 01/10/1996 | CN1114558A Depigmenting composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
| 01/09/1996 | US5482966 Oxime derivatives |
| 01/09/1996 | US5482960 Nonpeptide endothelin antagonists |
| 01/09/1996 | US5482957 Azole derivatives, process for their preparation and their use |
| 01/09/1996 | US5482953 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482944 Administering to alleviate tumor necrosis factor-related disorders |
| 01/09/1996 | US5482938 Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 01/09/1996 | US5482926 Growth factor IGF-Il |
| 01/09/1996 | US5482716 Medicaments |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
| 01/09/1996 | CA1337909C Non-peptide renin inhibitors |
| 01/07/1996 | CA2153213A1 Methods of inhibiting bone loss |
| 01/06/1996 | CA2153270A1 Hiv protease inhibitor combinations |
| 01/04/1996 | WO1996000238A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | WO1996000218A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000086A1 Therapeutic method and remedy for diabetes |
| 01/04/1996 | WO1996000082A1 Medical use of bromelain |
| 01/04/1996 | WO1996000077A1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |